SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-083574
Filing Date
2024-04-01
Accepted
2024-04-01 17:06:51
Documents
13
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 PRE 14A d726485dpre14a.htm PRE 14A 693077
2 GRAPHIC g726485g0082.jpg GRAPHIC 889
3 GRAPHIC g726485g06a08.jpg GRAPHIC 103732
4 GRAPHIC g726485g08c25.jpg GRAPHIC 110942
5 GRAPHIC g726485g13n02.jpg GRAPHIC 80356
6 GRAPHIC g726485g17p41.jpg GRAPHIC 92933
7 GRAPHIC g726485g45v56.jpg GRAPHIC 103051
8 GRAPHIC g726485g81g00.jpg GRAPHIC 63853
9 GRAPHIC g726485g81g01.jpg GRAPHIC 51846
10 GRAPHIC g726485g81g02.jpg GRAPHIC 4104
11 GRAPHIC g726485g81g03.jpg GRAPHIC 3414
12 GRAPHIC g726485g81g04.jpg GRAPHIC 3478
13 GRAPHIC g726485sp82.jpg GRAPHIC 1039
  Complete submission text file 0001193125-24-083574.txt   1548780
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38692 | Film No.: 24810740
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)